We are live on ! Find out more
KF

Krilogy Financial Portfolio holdings

AUM $3.11B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+20.67%
3 Year Est. Return
+53.36%
5 Year Est. Return
+52.45%
10 Year Est. Return
+165.81%
AUM
$358M
AUM Growth
+$36M
Cap. Flow
+$13.1M
Cap. Flow %
3.67%
Top 10 Hldgs %
55.42%
Holding
828
New
85
Increased
226
Reduced
177
Closed
83

Top Buys

Rank Stock Value
1
SCHF icon
Schwab International Equity ETF
SCHF
+$4.37M
2
MDYV icon
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
+$3.05M
3
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$2.78M
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$2.48M
5
SPHY icon
State Street SPDR Portfolio High Yield Bond ETF
SPHY
+$2.18M

Top Sells

Rank Stock Value
1
VOE icon
Vanguard Mid-Cap Value ETF
VOE
+$1.9M
2
AMLP icon
Alerian MLP ETF
AMLP
+$1.18M
3
SCHV
Schwab US Large-Cap Value ETF
SCHV
+$1.11M
4
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$953K
5
VUG icon
Vanguard Growth ETF
VUG
+$950K

Sector Composition

Rank Sector Weight
1 Technology 2.94%
2 Industrials 2.44%
3 Healthcare 2.26%
4 Financials 2.22%
5 Communication Services 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XXII
676
22nd Century Group
XXII
$1.47M
– –
0
– –
SCTL
677
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2K ﹤0.01%
+335
New +$2.29K
HYLD
678
DELISTED
High Yield ETF
HYLD
$2K ﹤0.01%
53
– –
VSM
679
DELISTED
Versum Materials, Inc.
VSM
$2K ﹤0.01%
50
– –
ETP
680
DELISTED
Energy Transfer Partners, L.P.
ETP
$2K ﹤0.01%
99
-235
-70% -$5.24K
SCMP
681
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$2K ﹤0.01%
200
– –
GG
682
DELISTED
Goldcorp Inc
GG
$2K ﹤0.01%
157
+57
+57% +$798
OIL
683
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$2K ﹤0.01%
309
– –
APVO icon
684
Aptevo Therapeutics
APVO
$5.47M
– –
0
– –
BBN icon
685
BlackRock Taxable Municipal Bond Trust
BBN
$969M
– –
0
– –
BBW icon
686
Build-A-Bear
BBW
$423M
$1K ﹤0.01%
+130
New +$1.32K
BCRX icon
687
BioCryst Pharmaceuticals
BCRX
$2.37B
$1K ﹤0.01%
200
– –
BLRX
688
BioLineRX
BLRX
$12.3M
$1K ﹤0.01%
2
– –
BMO icon
689
Bank of Montreal
BMO
$125B
$1K ﹤0.01%
12
– –
CLDX icon
690
Celldex Therapeutics
CLDX
$2.77B
$1K ﹤0.01%
40
– –
COLL icon
691
Collegium Pharmaceutical
COLL
$1.14B
$1K ﹤0.01%
100
– –
GSG icon
692
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.02B
$1K ﹤0.01%
60
– –
ILMN icon
693
Illumina
ILMN
$29.4B
$1K ﹤0.01%
6
+2
+50% +$346
KDP icon
694
Keurig Dr Pepper
KDP
$40.4B
$1K ﹤0.01%
11
-297
-96% -$27.8K
KR icon
695
Kroger
KR
$34.8B
$1K ﹤0.01%
+46
New +$1.3K
MSA icon
696
Mine Safety
MSA
$6.74B
$1K ﹤0.01%
26
– –
PFLT icon
697
PennantPark Floating Rate Capital
PFLT
$681M
$1K ﹤0.01%
96
– –
PJT icon
698
PJT Partners
PJT
$4.37B
$1K ﹤0.01%
+13
New +$486
QURE icon
699
uniQure
QURE
$2.68B
$1K ﹤0.01%
200
– –
SCYX icon
700
SCYNEXIS
SCYX
$37M
$1K ﹤0.01%
4
– –
26 27
28
29 30

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Krilogy Financial's Q2 2017 Portfolio in Review

As of Q2 2017, Krilogy Financial held 828 positions worth $358M, up 11% from $322M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Krilogy Financial deployed $13.1M of net new capital in Q2 2017, opening 85 new positions and adding to 226 existing holdings. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 82,259 shares worth $2.19M.

By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2.8% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap Value ETF, an estimated $1.9M trimmed.

  • Krilogy Financial's largest Q2 2017 buy was State Street SPDR Portfolio High Yield Bond ETF: 82,259 shares worth $2.19M.
  • Krilogy Financial added most to Schwab International Equity ETF in Q2 2017, an estimated $4.37M increase.
  • Krilogy Financial's biggest Q2 2017 reduction was Vanguard Mid-Cap Value ETF, cutting an estimated $1.9M.
  • Krilogy Financial fully exited Horizon Bancorp in Q2 2017, selling an estimated $196K.
  • Krilogy Financial's ten largest holdings make up 55% of its $358M portfolio in Q2 2017.
  • Krilogy Financial opened 85 new positions and closed 83 in Q2 2017.
  • Krilogy Financial's portfolio value rose 11% quarter-over-quarter to $358M.

Based on Krilogy Financial's 13F filing for Q2 2017, filed 15 Aug 2017.